SKK
ICPT

Shepherd Kaplan Krochuk’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,498
Closed -$234K – 467
2014
Q4 		$234K Hold
1,498
– – 0.04% 317
2014
Q3 		$355K Buy
1,498
+150
+11% +$38.2K 0.05% 267
2014
Q2 		$319K Sell
1,348
-996
-42% -$263K 0.03% 319
2014
Q1 		$773K Sell
2,344
-2,573
-52% -$868K 0.09% 165
2013
Q4 		$336K Hold
4,917
– – 0.04% 278
2013
Q3 		$339K Buy
+4,917
New +$243K 0.05% 253

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shepherd Kaplan Krochuk's ICPT Position: Q1 2015 in Review

Shepherd Kaplan Krochuk sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015, closing a stake of 1,498 shares — an estimated $234K sold.

Shepherd Kaplan Krochuk first reported a position in ICPT in Q3 2013 and held it in 6 quarters. The position peaked at $773K in Q1 2014. 200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.

  • Shepherd Kaplan Krochuk reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 1,498 Intercept Pharmaceuticals, Inc. shares in Q1 2015, an estimated $234K.
  • Shepherd Kaplan Krochuk first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • Shepherd Kaplan Krochuk's Intercept Pharmaceuticals, Inc. position peaked at $773K in Q1 2014.
  • 200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2015, filed 15 May 2015.